EVOQ Remedies Balance Sheet Annual

BSE: 543500 | NSE: - | ISIN: INE0JVD01011 | Sector: Biotechnology & Drugs

1.80 0.00 (0.00%)Updated : 19 Aug 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Liabilities Shareholders' Equity	51.94	50.01	36.86	34.90
Cash Equivalents	0.01	0.21	0.12	0.15
Other Liabilities Total	0.00	-	-	-
Long Term Debt	0.00	0.00	0.00	0.00
Common Stock Total	24.90	24.90	13.61	13.60
Other Current Assets Total	12.58	10.83	0.32	7.62
Total Assets	51.94	50.01	36.86	34.90
Total Equity	44.30	44.54	25.24	24.79
Retained Earnings( Accumulated Deficit)	19.40	19.64	11.64	11.19
Total Common Shares Outstanding	2.49	2.49	1.36	1.36
Tangible Book Valueper Share Common Eq	17.79	17.89	18.56	18.22
Total Liabilities	7.64	5.47	11.62	10.11
Total Debt	0.07	0.00	4.24	9.58
Cashand Short Term Investments	0.01	0.21	0.12	0.15
Total Receivables Net	37.51	36.53	33.28	25.08
Notes Payable/ Short Term Debt	0.07	0.00	4.24	9.58
Deferred Income Tax	0.00	0.00	0.00	0.00
Accounts Receivable- Trade Net	3.85	8.62	1.74	17.22
Property/ Plant/ Equipment Total- Net	0.17	0.22	0.01	0.01
Total Current Liabilities	7.64	5.47	11.62	10.11
Total Inventory	1.67	2.22	3.13	2.03
Accounts Payable	0.76	3.50	3.28	-0.54
Other Currentliabilities Total	6.81	1.98	4.10	1.07
Total Long Term Debt	0.00	0.00	0.00	0.00
Total Current Assets	51.77	49.79	36.85	34.89
period Length	0.00	0.00	0.00	0.00
Other Long Term Assets Total	-	0.00	0.00	0.00
Note Receivable- Long Term	-	0.00	0.00	0.00
Other Equity Total	-	-	-0.01	-